Inovio Pharmaceuticals (NASDAQ:INO) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of Inovio Pharmaceuticals (NASDAQ:INO – Free Report) in a report released on Monday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Inovio Pharmaceuticals Trading Down 4.0 % Shares of NASDAQ:INO opened at $0.38 on Monday. The firm has a market cap of $103.60 million, a price-to-earnings […]

Leave a Reply

Your email address will not be published.

Previous post Aspen Technology (NASDAQ:AZPN) Lifted to “Hold” at StockNews.com
Next post Bilibili (NASDAQ:BILI) Stock Rating Lowered by UBS Group